Showing 8 of 88 recruiting trials for “giant-cell-glioblastoma”
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
👨⚕️ David S Baskin, MD, Houston Methodist Neurological Institute📍 1 site📅 Started Dec 2017View details ↗
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
👨⚕️ Francisco Diaz-Mitoma, MD, Variation Biotechnologies Inc.📍 12 sites📅 Started Dec 2017View details ↗
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
👨⚕️ John Boockvar, MD, Lenox Hill Hospital-Northwell Health📍 1 site📅 Started Jun 2017View details ↗
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
👨⚕️ Lung-Ji Chang, PhD, Shenzhen Geno-Immune Medical Institute📍 1 site📅 Started May 2017View details ↗
RecruitingNCT07420543 ↗
Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
RecruitingNCT00083512 ↗
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
👨⚕️ Kevin A Camphausen, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jun 2004View details ↗
← PreviousPage 5 of 5
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →